-

OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth Initiatives

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority investment with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) as part of its accelerated national growth strategy. The collaboration marks a significant milestone for OrangeTwist, enabling new clinical, operational, and technological synergies with a global leader in medical services and clinic operations.

In conjunction with this announcement, OrangeTwist has acquired six additional med spa locations in Colorado and Nevada, expanding its footprint to 24 locations across 6 states, including California, Texas, Washington, Nevada, Colorado, and New Jersey. The expansion reinforces OrangeTwist’s mission to scale its clinically grounded, client-centric model of non-invasive aesthetic care nationwide.

“We are thrilled to deepen our strategic partnership with SBC Medical Group Holdings while expanding our presence in high-growth markets,” said Robert Settembro, CEO of OrangeTwist. “This next chapter allows us to bring exceptional aesthetic experiences to more communities while leveraging SBC’s global expertise. We remain focused on high-quality care, best-in-class providers, and innovative services that continue to differentiate OrangeTwist in a rapidly growing aesthetic landscape.”

Through the alliance, OrangeTwist and SBC Medical will collaborate on clinical protocol development, advanced technology integration, and operational scalability, positioning the company for accelerated market leadership and long-term strategic growth across both domestic and international markets.

OrangeTwist is backed by leading private equity firms Hildred and Athyrium Capital Management, providing institutional support for continued organic expansion, strategic acquisitions, and long-term platform growth.

“We believe the U.S. aesthetic market represents a compelling growth opportunity,” said Stephen Hallenbeck, Partner at Hildred. “We believe OrangeTwist’s differentiated model, combined with its expanding footprint and strategic partnerships, positions the company for scalable and sustainable growth.”

OrangeTwist remains committed to elevating the standard of non-invasive aesthetic care through continued innovation, premium client experiences, and disciplined expansion.

About OrangeTwist

OrangeTwist is a leading provider of medically supervised aesthetic and wellness treatments, delivering real results through innovative, non-invasive services and exceptional client experiences. With 24 locations across 6 states, OrangeTwist offers a comprehensive portfolio of injectable, energy-based, and wellness treatments supported by strong clinical oversight and best-in-class operational systems.
For more information, visit www.orangetwist.com.

Contacts

OrangeTwist
Denise Keeler
denise@orangetwist.com

OrangeTwist


Release Versions

Contacts

OrangeTwist
Denise Keeler
denise@orangetwist.com

More News From OrangeTwist

AleraCare and Pure Healthcare Complete Merger, Creating a Leading National Platform for Ambulatory Infusion and Specialty Care

PHOENIX & TAYLORSVILLE, Utah--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease and other autoimmune conditions, today announced the completion of their previously announced merger. The transaction unites two clinicall...

Hildred Named to Inc.’s 2025 List of Founder-Friendly Investors

NEW YORK--(BUSINESS WIRE)--Hildred, a lower middle-market healthcare private equity firm, today announced that it has been named to Inc.'s 2025 Founder-Friendly Investors list. The prestigious list celebrates the investors that believe in backing founder-led businesses and helping them thrive. On behalf of Hildred, Co-Founders and Managing Partners Andrew Goldman and David Solomon stated: “Our role as a trusted partner to our portfolio companies and their executive management teams is a core te...

AleraCare Appoints Joseph Cosgrove as Chief Executive Officer and Member of the Board of Directors

PHOENIX--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., today announced that its Board of Directors has unanimously appointed Joseph Cosgrove as the company’s new Chief Executive Officer and as a member of the Board. Russ Corvese will retire as Chief Executive Officer, effective October 13, 2025, and will serve as an advisor to the business during the transition. This leadership transition comes at a pivotal time for the company, as A...
Back to Newsroom